Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Amortization - Intangibles (2024 - 2025)

CorMedix (CRMD) has disclosed Amortization - Intangibles for 2 consecutive years, with $10.1 million as the latest value for Q4 2025.

  • Quarterly Amortization - Intangibles rose 19360.22% to $10.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.9 million through Dec 2025, changed N/A year-over-year, with the annual reading at $13.9 million for FY2025, 8792.31% up from the prior year.
  • Amortization - Intangibles hit $10.1 million in Q4 2025 for CorMedix, up from $3.6 million in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $10.1 million in Q4 2025 to a low of $51948.0 in Q3 2024.